146 related articles for article (PubMed ID: 27554932)
1. Spectroscopic studies on the interaction of DNA with the copper complexes of NSAIDs lornoxicam and isoxicam.
Goswami S; Ray S; Sarkar M
Int J Biol Macromol; 2016 Dec; 93(Pt A):47-56. PubMed ID: 27554932
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
4. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
Chakraborty S; Sehanobish E; Sarkar M
J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
[TBL] [Abstract][Full Text] [Related]
5. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding.
Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug diflunisal interacting with Cu(II). Structure and biological features.
Fountoulaki S; Perdih F; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2011 Dec; 105(12):1645-55. PubMed ID: 22071090
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, micellization behavior, antimicrobial and intercalative DNA binding of some novel surfactant copper(II) complexes containing modified phenanthroline ligands.
Nagaraj K; Ambika S; Rajasri S; Sakthinathan S; Arunachalam S
Colloids Surf B Biointerfaces; 2014 Oct; 122():151-157. PubMed ID: 25033435
[TBL] [Abstract][Full Text] [Related]
8. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity.
Jozefíková F; Perontsis S; Koňáriková K; Švorc Ľ; Mazúr M; Psomas G; Moncol J
J Inorg Biochem; 2022 Mar; 228():111696. PubMed ID: 35030390
[TBL] [Abstract][Full Text] [Related]
9. Multispectroscopic studies on the interaction of a copper(ii) complex of ibuprofen drug with calf thymus DNA.
Shahabadi N; Shiri F
Nucleosides Nucleotides Nucleic Acids; 2017 Feb; 36(2):83-106. PubMed ID: 27835056
[TBL] [Abstract][Full Text] [Related]
10. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
[TBL] [Abstract][Full Text] [Related]
11. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
Cini R; Tamasi G; Defazio S; Hursthouse MB
J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
[TBL] [Abstract][Full Text] [Related]
12. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
[TBL] [Abstract][Full Text] [Related]
13. Interaction of a common painkiller piroxicam and copper-piroxicam with chromatin causes structural alterations accompanied by modulation at the epigenomic/genomic level.
Goswami S; Sanyal S; Chakraborty P; Das C; Sarkar M
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2048-2059. PubMed ID: 28411076
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) complexes with antimicrobial drug flumequine: structure and biological evaluation.
Chalkidou E; Perdih F; Turel I; Kessissoglou DP; Psomas G
J Inorg Biochem; 2012 Aug; 113():55-65. PubMed ID: 22694822
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and DNA interaction studies of new copper complex containing pseudoephedrine hydrochloride drug.
Shahabadi N; Akhtarshenas S; Hadidi S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(9):680-699. PubMed ID: 30942140
[TBL] [Abstract][Full Text] [Related]
16. Interaction of a copper (II) complex containing an artificial sweetener (aspartame) with calf thymus DNA.
Shahabadi N; Khodaei MM; Kashanian S; Kheirdoosh F
Spectrochim Acta A Mol Biomol Spectrosc; 2014; 120():1-6. PubMed ID: 24177861
[TBL] [Abstract][Full Text] [Related]
17. Copper(II) interacting with the non-steroidal antiinflammatory drug flufenamic acid: structure, antioxidant activity and binding to DNA and albumins.
Tolia C; Papadopoulos AN; Raptopoulou CP; Psycharis V; Garino C; Salassa L; Psomas G
J Inorg Biochem; 2013 Jun; 123():53-65. PubMed ID: 23528572
[TBL] [Abstract][Full Text] [Related]
18. Copper(II) complexes with N,N'-dialkyl-1,10-phenanthroline-2,9-dimethanamine: synthesis, characterization, DNA-binding thermodynamical and kinetic studies.
Wang ZM; Lin HK; Zhou ZF; Xu M; Liu TF; Zhu SR; Chen YT
Bioorg Med Chem; 2001 Nov; 9(11):2849-55. PubMed ID: 11597465
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and equilibria for the formation of a new DNA metal-intercalator: the cyclic polyamine Neotrien/copper(II) complex.
Biver T; Secco F; Tinè MR; Venturini M
J Inorg Biochem; 2004 Jan; 98(1):33-40. PubMed ID: 14659630
[TBL] [Abstract][Full Text] [Related]
20. Binding Studies of Isoxsuprine Hydrochloride to Calf Thymus DNA Using Multispectroscopic and Molecular Docking Techniques.
Salehzadeh S; Hajibabaei F; Moghadam NH; Sharifinia S; Khazalpour S; Golbedaghi R
J Fluoresc; 2018 Jan; 28(1):195-206. PubMed ID: 28986738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
